Trade and invest in health and biotech stocks with Admiral Markets!
The world is on edge as it tries to find a solution to the coronavirus pandemic, with the markets having lost close to 30% in the last few weeks.
We are delighted to announce a small, but important extension of our coverage of the health and biotechnology companies, now available as CFDs (Contracts for Difference) on our Trade.MT5 account:
- Moderna Inc (MRNA)
- DBV Technologies SA - ADR (DBVT)
- Takeda Pharmaceutical Co Ltd - ADR (TAK)
Also, the following common stocks are now available to our clients with Invest.MT5 account:
- Emergent BioSolutions Inc (EBS)
- Biomerica Inc (BMRA)
- BioNTech SE - ADR (BNTX)
- Heat Biologics Inc (HTBX)
- Vaxart Inc (VXRT)
- Vir Biotechnology Inc (VIR)
- Tonix Pharmaceuticals Holding Corp (TNXP)
These instruments join our existing line up of health and biotech stocks, including:
- 102 biotechnology companies, including AbbVie Inc (ABBV), Biogen InC (BIIB), Gilead Sciences Inc (GILD)
- 70 pharmaceutical companies, including Takeda Pharmaceutical Co Ltd (4502.JP), GlaxoSmithKline (GSK), Eli Lilly & Co (LLY), Johnson and Johnson (JNJ), Pfizer (PFE)
Additionally, you can access more than 100 companies in other segments of the healthcare industry plus 13 exchange-traded funds (ETFs) specialised in healthcare & biotech.